Topical CCL3 Is Well-Tolerated and Improves Liver Function in Diabetic Mice: Evidence from a 14-Day Toxicity Study.

In contrast, mice treated with CCL3 at either dose showed reduced hepatocyte size, and trended toward reduced necrosis scores, albeit they did not reach statistical significance ( Figure 4 B–E).

also in 111,027 other papers